Tens of thousands of lawsuits over defective Transvaginal Mesh implants have been settled over the last two years for billions of dollars. Transvaginal surgical mesh (TVM) implants were once believed to be an innovation with great potential for many women suffering from conditions such as stress urinary incontinence (SUI) and pelvic organ prolapse (POP). But defectively designed and poorly tested transvaginal mesh products have been considered to be the source of additional health concerns due to the complications occurs after implantation .There are thousands of women still suffering who have not had their Transvaginal Mesh removed. According to the FDA, the transvaginal placement of the surgical mesh may put women at a greater risk for POP mesh complications than other surgical options.
As per experts it is estimated that the total number of claims exceeds 100,000 lawsuits against seven major mesh device manufacturers, including C.R. Bard, Ethicon (a Johnson & Johnson subsidiary), American Medical Systems and Boston Scientific. The lawsuits are filed in the U.S. District Court for the Southern District of West Virginia under Chief Judge Joseph R. Goodwin. The most number of lawsuits are filed against American Medical Systems and Ethicon. All of the lawsuits involve similar allegations that the transvaginal mesh devices were that the manufacturers have not disclose and mispresented the severe risks associated with transvaginal mesh implant and falsely marketing the device without adequate warning of it adverse effects.
Recently a woman named Shirley filed a lawsuit against the mesh manufacturers. According to Shirley she was implanted with a transvaginal mesh bladder sling in 2006 to treat incontinence. After few months of the implantation she was suffering from pain and discomfort. She complained her doctor of that and requests him to take it out but the doctor assured her that the surgery was a success. The woman blame her doctor for being duped, but mainly accuse the manufacturers of concealing known risks, failing to warn about side effects, and continuing to market the mesh as safe and effective device. As per the FDA guidelines, Patients should be notify by provider that mesh is permanent, once implanted it may not be possible to remove. The implanted mesh may require additional surgery that may or may not correct the complication and the provider should be careful in most cases, mesh is not required and all complications can be avoided by not using it.
Few months ago two final orders have been issued by the U.S Food and Drug Administration to manufacturers and the public, the first one is to reclassify these medical devices from class II, which generally includes moderate-risk devices, to class III, which generally includes high-risk devices, and a second order that requires manufacturers to submit a premarket approval (PMA) application to support the safety and effectiveness of surgical mesh for the transvaginal repair of POP. If you received a transvaginal mesh implant in the past, and you have since suffered mesh infection, mesh erosion or another major side effect, Contact Drugsclaim.com for a legal battle against the manufacturers of defective device. We have an experience team of attorney who will assess your case and determine the severity and chances of receiving compensation. Vaginal mesh settlements could result in thousands of dollars, if not hundreds of thousands of dollars, in compensation to help pay for medical expenses, missed work, pain and suffering, and more.